CAMBRIDGE, Thursday 1 June 2023 鈥� 糖心原创 was featured in an article in Forbes by Senior Contributor and Synthetic biology author John Cumbers.
The piece, titled "Meet The Company Democratising Access To Human Cells" covers the launch of 糖心原创's Custom ioDisease Model CellsTM offering at the SynBioBeta conference and how this offer has incredible potential for rare diseases, where conventional drug discovery methods often fall short. The piece also features Everlum.bio, who are already using 糖心原创's cells to develop therapies for rare diseases.
